Moreover, Myd88−/− mice are susceptible to systemic fungal infections—including systemic candidiasis—however MYD88-deficient patients do not develop candidiasis or other fungal disease, likely due to compensatory effects of other PRRs, primarily of CLRs [132,133]. This evidence concerns the gene MYD88 and fungal infectious disease.